Drugs / 18F-FMPP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04596527 | Sep 2020 → Jun 2022 | coronary artery disorder | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-FMPP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04596527 ↗ |
| Modality | Diagnostic / imaging agent | “18F-FMPP is a novel PET myocardial perfusion imaging (MPI) tracer” NCT04596527 ↗ |
| Route | Intravenous | “All subjects will receive rest and stress IV boluses of 18F-FMPP injections in a large peripheral vein.” NCT04596527 ↗ |